Digitek Defendants Seek to Block Class Cert.
Pharmaceutical company defendants in multidistrict product liability litigation over the recalled heart medication Digitek are asking a federal court to nix the plaintiffs' bid for class certification, saying the named plaintiffs'...To view the full article, register now.
Already a subscriber? Click here to view full article